Investigators assessed the use of different combined oral contraceptive pills for the treatment and management of polycystic ovary syndrome, as an update to recent evidence-based guidelines.
Wegovy is a glucagon-like peptide-1 receptor agonist.
A greater proportion of patients who received oral semaglutide achieved superior weight loss after 68 weeks compared with those who received placebo.
Researchers analyzed the relationship between dietary choline and betaine intake and serum lipids, blood pressure, and glycemic markers among individuals with obesity.
Investigators from Texas Tech University searched publication databases for studies evaluating risk for diabetes mellitus, hypertension, dyslipidemia, and atherosclerotic macrovascular disease in the setting of autism spectrum disorder.
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Semaglutide is a glucagon-like peptide-1 receptor agonist.
From 2010 to 2019, greatest percent increase in cancer deaths and DALYs was from metabolic risks
The approval was based on data from a phase 4 study which included patients 12 to 17 years of age with a BMI at the 95th percentile or greater standardized for age and sex.
Three-quarters of all psychiatric disorders occur by early adulthood (mid-20s). This fact suggests that bio-psychosocial factors occurring from the fetal period through early adulthood could play a crucial role in risk. This nonsystematic review sought to synthesize key epidemiological evidence of relevant risk factors.
